mebendazole has been researched along with Cancer of Prostate in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Docetaxel chemotherapy in prostate cancer has a modest impact on survival." | 1.56 | Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment. ( Dufès, C; Hewit, K; James, D; Leung, HY; Munnings-Tomes, S; Patel, R; Rushworth, LK; Shanks, E; Somani, S; Straube, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rushworth, LK | 1 |
| Hewit, K | 1 |
| Munnings-Tomes, S | 1 |
| Somani, S | 1 |
| James, D | 1 |
| Shanks, E | 1 |
| Dufès, C | 1 |
| Straube, A | 1 |
| Patel, R | 1 |
| Leung, HY | 1 |
1 other study available for mebendazole and Cancer of Prostate
| Article | Year |
|---|---|
Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Prolifera | 2020 |